Y-Mabs Therapeutics Inc
XNAS: YMAB
Y-Mabs Therapeutics Inc Live Share Price Today, Share Analysis and Chart
about
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved prod...
Read More
4.36
-0.16
(-3.54%)
111.1K
XNAS Volume
XNAS 11 Jul, 2025 5:30 PM (EDT)
Low Financial Strength
Expensive Valuation
Technically Bearish
Weak Stock
These stocks are the ones with poor quality, financials and technicals. This indicates that investors should be highly watchful with these stocks.
View Similar
Embed DVM
Y-Mabs Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..